Could Brexit crush 5%+ yields at GlaxoSmithKline plc and at Admiral Group plc?

Would Brexit turmoil cause GlaxoSmithKline plc (LON:GSK) and Admiral Group plc (LON:ADM) to cut their dividend payouts?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The latest polls and betting odds suggest that the outcome of next week’s EU referendum will be very finely balanced. If you’re an income investor, it could be worth asking whether any of the dividends in your portfolio are likely to be affected by a Brexit.

Safe as houses?

Pharma giant GlaxoSmithKline (LSE: GSK) is a Neil Woodford favourite, and a fixture in many investors’ income portfolios. The stock’s current 5.7% forecast yield is well above the FTSE 100 average of 4%.

Glaxo shares have outperformed the market and made modest gains so far in 2016, as the outlook for the group has improved. Core earnings per share rose by 14% during the first quarter, compared to the same period last year.

Glaxo now expects full-year core earnings growth of between 10% and 12%, suggesting a full-year figure of about 85p per share. This should be enough to cover the firm’s guided dividend of 80p per share.

Although some risks remain for Glaxo shareholders, in my view Brexit isn’t one of them. Glaxo operates in most of the world’s major economies and currencies. The firm’s business is built around its portfolio of unique products, most of which have patent protection.

I can’t see any logical reason why a UK vote to leave the EU would be likely to have a material effect on Glaxo’s sales, or its ability to pay a reliable dividend. In my view, any short-term dips as a result of the referendum could be a good buying opportunity.

Will insurance be affected?

Shares in motor insurance group Admiral Group (LSE: ADM) have risen by 25% over the last year. The FTSE 100 has fallen by 11% over the same period, making Admiral a clear winner. But while Admiral’s shares surged higher following the group’s results in March, progress since then has been uncertain.

One reason for this may simply be that Admiral’s shares now look quite fully priced. Earnings per share are expected to be flat this year and to rise by a relatively modest 6% in 2017. Set against this level of growth, I think Admiral’s 2016 forecast P/E of 17.4 is probably high enough.

However, Brexit fears may also be playing a part. The group has insurance or price comparison businesses in France, Spain and Italy. None of these make much money for the group at the moment, but international expansion is a key part of Admiral’s growth strategy.

A Brexit vote could potentially make it harder for UK companies to run regulated financial businesses in Europe. Personally, I suspect this wouldn’t be a big issue, but it’s definitely a risk. We simply don’t know how an EU exit would be handled.

Given all of this, how safe is Admiral’s dividend? The firm’s total payout is expected to be 112.7p per share this year, giving a forecast yield of 6.2%.

My view is that while Admiral is banking on its European and US operations for future growth, the current dividend is funded by Admiral’s UK business. I don’t see any reason why a Brexit would have an immediate impact on Admiral’s dividend.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

2 top growth stocks to consider for an ISA in April

The UK market is home to some fantastic under-the-radar growth stocks trading at very reasonable valuations. Here are two of…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Could thinking like Warren Buffett help create a market-beating ISA?

Christopher Ruane zooms in on some aspects of Warren Buffett's investing approach he thinks could help an ambitious ISA investor…

Read more »

British pound data
Investing Articles

£10,000 invested in a FTSE 100 index tracker at the start of March is now worth…

Anyone who invested money in a FTSE 100 index tracker at the start of the month may wish to look…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Should investors consider Rolls-Royce shares as war rocks global markets?

Investors who thought Rolls-Royce shares had grown too expensive might have second thoughts as Iran turmoil rattles the FTSE 100,…

Read more »

Young black woman walking in Central London for shopping
Investing Articles

Some lucky ISA investors could pick up £2,000 for free in the next month. Here’s how

The UK government is handing out free money to some ISA investors to help them save for retirement. Here’s a…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Is this the best time to buy dividend shares since Covid-19?

A volatile stock market gives investors a chance to buy shares with unusually high dividend yields. Stephen Wright highlights one…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Are we staring at a once-in-a-decade chance to buy this beaten-down UK growth stock?

Investors couldn't get enough of this FTSE 100 growth stock, but the last 10 years have been pretty frustrating. Could…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

What I look for when searching for shares to buy

There’s a lot that goes into finding shares to buy. Ultimately though, it comes down to two things: numbers that…

Read more »